Related references
Note: Only part of the references are listed.Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
Charles A. Dinarello
BLOOD (2011)
Population pharmacokinetic analysis of sorafenib in patients with solid tumours
Lokesh Jain et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
A clinical perspective of IL-1β as the gatekeeper of inflammation
Charles A. Dinarello
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Paw Inflammation Model in Dogs for Preclinical Pharmacokinetic/Pharmacodynamic Investigations of Nonsteroidal Anti-Inflammatory Drugs
E. C. Jeunesse et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Antiarthritis Effect of a Novel Bruton's Tyrosine Kinase (BTK) Inhibitor in Rat Collagen-Induced Arthritis and Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling: Relationships between Inhibition of BTK Phosphorylation and Efficacy
Lichuan Liu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Pharmacokinetic-Pharmacodynamic Disease Progression Model for Effect of Etanercept in Lewis Rats with Collagen-Induced Arthritis
Hoi-Kei Lon et al.
PHARMACEUTICAL RESEARCH (2011)
Integration of efficacy, pharmacokinetic and safety assessment of interleukin-1 receptor antagonist in a preclinical model of arthritis
Anne-Marie Zuurmond et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2011)
Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA
J. L. Nam et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Population Pharmacokinetics of Therapeutic Monoclonal Antibodies
Nathanael L. Dirks et al.
CLINICAL PHARMACOKINETICS (2010)
Anti-IL-1 molecules: New comers and new indications
Anna Molto et al.
JOINT BONE SPINE (2010)
Pharmacokinetics of Biotech Drugs: Peptides, Proteins and Monoclonal Antibodies
Jiunn H. Lin
CURRENT DRUG METABOLISM (2009)
Anakinra for Rheumatoid Arthritis: A Systematic Review
Marty Mertens et al.
JOURNAL OF RHEUMATOLOGY (2009)
Quantitative Dynamic Models of Arthritis Progression in the Rat
Justin C. Earp et al.
PHARMACEUTICAL RESEARCH (2009)
Pharmacokinetic modelling of interleukin-1 receptor antagonist in plasma and cerebrospinal fluid of patients following subarachnoid haemorrhage
Ivelina Gueorguieva et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Monoclonal Antibody Pharmacokinetics and Pharmacodynamics
W. Wang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Leveraging prior quantitative knowledge to guide drug development decisions and regulatory science recommendations: Impact of FDA pharmacometrics during 2004-2006
Yaning Wang et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Modeling corticosteroid effects in a rat model of rheumatoid arthritis I: Mechanistic disease progression model for the time course of collagen-induced arthritis in lewis rats
Justin C. Earp et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Modeling corticosteroid effects in a rat model of rheumatoid arthritis II: Mechanistic pharmacodynamic model for dexamethasone effects in lewis rats with collagen-induced arthritis
Justin C. Earp et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
Daniel Tracey et al.
PHARMACOLOGY & THERAPEUTICS (2008)
Utility of animal models for identification of potential therapeutics for rheumatoid arthritis
M. Hegen et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
New therapies for treatment of rheumatoid arthritis
Josef S. Smolen et al.
LANCET (2007)
Model-based drug development
R. L. Lalonde et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Pharmacokinetic/pharmacodynamic modelling of NSAIDs in a model of reversible inflammation in the cat
JM Giraudel et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Additive bone-protective effects of anabolic treatment when used in conjunction with RANKL and tumor necrosis factor inhibition in two rat arthritis models
G Schett et al.
ARTHRITIS AND RHEUMATISM (2005)
The usefulness and the limitations of animal models in identifying targets for therapy in arthritis
PH Wooley
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2004)
A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate
SB Cohen et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
The pharmacokinetics of interleukin-1 receptor antagonist in Chinese subjects with rheumatoid arthritis
DM Chang et al.
PHARMACOLOGICAL RESEARCH (2004)
Perls-speaks-NONMEM (PsN) - a Perl module for NONMEM related programming
L Lindbom et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2004)
Pharmacokinetics of anakinra in subjects with different levels of renal function
BB Yang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Population pharmacokinetics and pharmacodynamics of sotalol in pediatric patients with supraventricular or ventricular tachyarrhythmia
J Shi et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2001)
Mechanisms of disease: Cytokine pathways and joint inflammation in rheumatoid arthritis.
EHS Choy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
